These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 27121319

  • 21. TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.
    Fan J, Zhang Y, Mu J, He X, Shao B, Zhou D, Peng W, Tang J, Jiang Y, Ren G, Xiang T.
    Clin Epigenetics; 2018 Aug 03; 10(1):103. PubMed ID: 30075814
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.
    Mizuguchi Y, Saiki Y, Horii A, Fukushige S.
    Cancer Med; 2016 Sep 03; 5(9):2522-33. PubMed ID: 27457352
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer.
    Chapman CG, Mariani CJ, Wu F, Meckel K, Butun F, Chuang A, Madzo J, Bissonnette MB, Kwon JH, Godley LA.
    Sci Rep; 2015 Dec 03; 5():17568. PubMed ID: 26631571
    [Abstract] [Full Text] [Related]

  • 27. MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.
    Chuang KH, Whitney-Miller CL, Chu CY, Zhou Z, Dokus MK, Schmit S, Barry CT.
    Hepatology; 2015 Aug 03; 62(2):466-80. PubMed ID: 25820676
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. GADD45A binds R-loops and recruits TET1 to CpG island promoters.
    Arab K, Karaulanov E, Musheev M, Trnka P, Schäfer A, Grummt I, Niehrs C.
    Nat Genet; 2019 Feb 03; 51(2):217-223. PubMed ID: 30617255
    [Abstract] [Full Text] [Related]

  • 30. TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells.
    Fu R, Ding Y, Luo J, Yu L, Li CL, Li DS, Guo SW.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 28341638
    [Abstract] [Full Text] [Related]

  • 31. TET1 Regulates Nestin Expression and Human Airway Smooth Muscle Proliferation.
    Wang R, Liao G, Tang DD.
    Am J Respir Cell Mol Biol; 2024 Oct 22; 71(4):420-429. PubMed ID: 38861343
    [Abstract] [Full Text] [Related]

  • 32. Ten-eleven translocation 1 functions as a mediator of SOD3 expression in human lung cancer A549 cells.
    Kamiya T, Nakahara R, Mori N, Hara H, Adachi T.
    Free Radic Res; 2017 Mar 22; 51(3):329-336. PubMed ID: 28351182
    [Abstract] [Full Text] [Related]

  • 33. TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.
    Tsai YP, Chen HF, Chen SY, Cheng WC, Wang HW, Shen ZJ, Song C, Teng SC, He C, Wu KJ.
    Genome Biol; 2014 Dec 03; 15(12):513. PubMed ID: 25517638
    [Abstract] [Full Text] [Related]

  • 34. Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo-YAP1 pathway.
    Liu D, Liu Y, Zhu W, Lu Y, Zhu J, Ma X, Xing Y, Yuan M, Ning B, Wang Y, Jia Y.
    BMC Med; 2023 Apr 05; 21(1):134. PubMed ID: 37016382
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism.
    Zhao R, Liu Z, Xu W, Song L, Ren H, Ou Y, Liu Y, Wang S.
    Cancer Med; 2020 Apr 05; 9(7):2551-2563. PubMed ID: 32017451
    [Abstract] [Full Text] [Related]

  • 38. Decreased expression of ten-eleven translocation 1 protein is associated with some clinicopathological features in gastric cancer.
    Frycz BA, Murawa D, Borejsza-Wysocki M, Marciniak R, Murawa P, Drews M, Kołodziejczak A, Tomela K, Jagodziński PP.
    Biomed Pharmacother; 2014 Mar 05; 68(2):209-12. PubMed ID: 24507562
    [Abstract] [Full Text] [Related]

  • 39. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
    Yatagai N, Saito T, Akazawa Y, Hayashi T, Yanai Y, Tsuyama S, Ueyama H, Murakami T, Watanabe S, Nagahara A, Yao T.
    Virchows Arch; 2019 Mar 05; 474(3):315-324. PubMed ID: 30554333
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.